Blueprint Medicines (BPMC) Q4 2024 Earnings

30OctConfirmed
Q4 2023
Q2 2024
Q3 2024
Q4 2024
-2.04
-0.88
0.29
1.45

Details

Expected EPS
-0.961095
Actual EPS
-0.89
Surprise EPS
0.07
Surprise Percent
+7.4%

Description

Blueprint Medicines (BPMC) has reported earnings of -0.89 per share for Q4 2024.

0 Comments

Share your thoughts